07:35 AM EDT, 08/04/2025 (MT Newswires) -- Twist Bioscience ( TWST ) reported fiscal Q3 net income Monday of $0.33 per diluted share, swinging from a loss of $1.47 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.55 per share.

Revenue for the quarter ended June 30 was $96.1 million, up from $81.5 million a year earlier.

Analysts polled by FactSet expected $95.6 million.

For fiscal 2025, the company expects revenue in the range of $374 million to $376 million, compared with a prior guidance of $372 million to $379 million. Analysts surveyed by FactSet expect $376.5 million.

For fiscal Q4 2025, Twist Bioscience ( TWST ) projects revenue in the range of $96 million to $98 million. Analysts polled by FactSet expect $99 million.